Free Trial

Oculis (OCS) Institutional Ownership

Oculis logo
$21.41 +0.10 (+0.47%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$21.42 +0.01 (+0.05%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Oculis (NASDAQ:OCS)

Current
Institutional Ownership
Percentage
22.30%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$4.21M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$4.43M
Get OCS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oculis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

OCS Institutional Buying and Selling by Quarter

Oculis Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Citadel Advisors LLC22,911$389K0.0%N/A0.057%
2/17/2025 Bank of America Corp DE28,980$493K0.0%+58.2%0.072%
2/17/2025 Bellevue Group AG10,000$170K0.0%N/A0.025%
2/13/2025 XTX Topco Ltd13,249$225K0.0%N/A0.033%
2/12/2025 Geode Capital Management LLC16,744$284K0.0%+12.0%0.041%
1/24/2025 abrdn plc1,009,424$17.15M0.0%+23.0%2.492%
10/25/2024 abrdn plc820,553$10.06M0.0%-25.4%2.026%
5/14/2024 Nan Fung Group Holdings Ltd436,378$5.26M4.9%-15.9%1.077%
2/14/2024 Pivotal bioVenture Partners Investment Advisor LLC1,888,788$21.21M5.4%-14.9%5.190%
2/6/2024 Searle & CO.10,000$112K0.0%N/A0.027%
1/31/2024 abrdn plc1,452,741$15.98M0.0%N/A3.992%
1/16/2024 Compagnie Lombard Odier SCmA95,750$1.05M0.0%+47.3%0.263%
11/14/2023 Nan Fung Group Holdings Ltd606,684$6.67M5.4%-6.8%1.667%
11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC2,218,754$24.41M9.7%-6.8%6.097%
11/13/2023 Wolverine Asset Management LLC7,021$77K0.0%N/A0.019%
9/21/2023 Barclays PLC3,602$44K0.0%N/A0.010%
5/12/2023 Nan Fung Group Holdings Ltd651,100$4.84M3.3%N/A1.989%
5/1/2023 Compagnie Lombard Odier SCmA65,000$472K0.0%N/A0.199%
(Data available from 1/1/2016 forward)

OCS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OCS shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Oculis. The most heavily invested institutionals were Pivotal bioVenture Partners Investment Advisor LLC ($21.21M), abrdn plc ($17.15M), Nan Fung Group Holdings Ltd ($5.26M), Compagnie Lombard Odier SCmA ($1.05M), Bank of America Corp DE ($493K), Citadel Advisors LLC ($389K), and Geode Capital Management LLC ($284K).Learn more on OCS's institutional investors.

What percentage of Oculis stock is owned by institutional investors?

22.30% of Oculis stock is owned by institutional investors. Learn more on OCS's institutional investor holdings.

Which institutional investors have been buying Oculis stock?

Of the 11 institutional investors that purchased Oculis stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: abrdn plc ($1.64M), Nan Fung Group Holdings Ltd ($651.10K), Compagnie Lombard Odier SCmA ($95.75K), Citadel Advisors LLC ($22.91K), XTX Topco Ltd ($13.25K), Bank of America Corp DE ($10.67K), and Bellevue Group AG ($10K).

How much institutional buying is happening at Oculis?

Institutional investors have bought a total of 2,467,712 shares in the last 24 months. This purchase volume represents approximately $26.42M in transactions.

Which Oculis major shareholders have been selling company stock?

The following institutional investors have sold Oculis stock in the last 24 months: Pivotal bioVenture Partners Investment Advisor LLC ($492.41K), abrdn plc ($279.88K), and Nan Fung Group Holdings Ltd ($126.97K).

How much institutional selling is happening at Oculis?

Institutional investors have sold a total of 899,258 shares in the last 24 months. This volume of shares sold represents approximately $10.41M in transactions.



This page (NASDAQ:OCS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners